On a roll in Ireland, Alexion plots 200-job supply chain hub

Alexion ($AXLN), like many of its pharma peers, has moved some operations to Ireland to enjoy the country's low tax rate. Now, it's beefing up those operations: Thursday, the rare-disease drugmaker announced plans for its third Irish project, a new supply-chain facility that should produce around 200 jobs come 2016. More

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…